SHH and lung cancer: In another work on lung cancer cell lines (HCC and H1339), inhibition of the Shh pathway by a pharmacological Smo-inhibitor (vismodegib) resulted in a decrease of the population of CSCs measured by the ability of efflux of Hoechst 33342 (SP+ cells) using flow cytometry analysis [55].